Molina HealthcareMOH
Recorded

Molina Healthcare 2026 UBS Global Healthcare Conference

Review the key takeaways and the transcript of this earnings call.

Period 2026Duration36 minParticipants2

Transcript

Preview the first fifteen paragraphs, organized by speaker.

AJ RiceAnalyst

Wherever you want. I will sit here. I am sitting here on the edge. All right, I think we will get going with our next presentation. We are very pleased to have Molina Healthcare with us today, and Mark Keim is the Chief Financial Officer, is going to represent the group. Mark, thanks for participating in our conference this year. Coming out of the third quarter, what gives Molina confidence that the company is approaching a positive turn, particularly as it relates to Medicaid, and what remains your biggest source of uncertainty, if I could ask you?

Mark KeimCFO

Well, AJ, thanks for having us here, and it is always great to see you. Thanks so much. We outlined on our third quarter earnings call the building blocks to $9.50. That is a starting point. That is not guidance. That is also before the impacts of MLR year-over-year on the Medicaid business. You mentioned uncertainty. I would put it in the category of cautious optimism. But when we look at next year, the two big drivers, the membership impact of OB3, obviously with work requirements and biannual redeterminations, there is some uncertainty around membership. I think the environment for that is probably improved in the last few weeks. Guess we will talk more about that later this morning. But the other one is certainly rates versus trend. For Medicaid, we are coming off a 92.6% in our guidance for 2026. The building blocks to $9.50 assume no change to that for next year.

Mark KeimCFO

Any benefit on the MLR line is only upside to the $9.50.

AJ RiceAnalyst

Okay. And you have talked about embedded earnings of $9 that you hope to realize at some over the next few years. How much of that embedded earnings is due to an expectation and improvement of legacy Medicaid and Medicare margins, and what components of that are largely in place, and it is just a glide path to get to those, and what require future operating performance?

Mark KeimCFO

Yeah, so thanks for asking that. The $9 of embedded earnings, just to level set, I do not know how some of our competitors do it, but at Molina, embedded earnings are what we call a new store concept. It is not about changes to the legacy business. It is about new discrete pieces of business that we bring in, typically RFPs and acquisitions, things like that. So the $9 is truly incremental things, not the legacy business. I mentioned we would harvest $4 of the $9 of embedded earnings in 2027, and what that specifically comes from is the Florida CMS Kids contract. In 2026, we expect to lose about $1.50 on Florida CMS Kids. We expect to get that to at least break even in 2027. So that is $1.50. We announced that we would be leaving our MAPD or general issue Medicare business for 2027.

Mark KeimCFO

That currently loses $1, so that is a good guy for $1. Then finally, we have become very good at harvesting the leverage in our G&A administration ratios with growth. Next year, we will grow $3 billion from $42 billion to $45 billion of premium revenue. Associated with that, we will drive $1.50 of G&A efficiencies. So that is the $4 that we will harvest in 2027. The remaining $5 is for 2028 and 2029.

AJ RiceAnalyst

Okay. When you think about, I know you said you are not giving guidance for next year at this point, but when you think about first half, second half, is some of that $4 going to skew more to the back half, or you see that sort of evenly allocated over the year?

Mark KeimCFO

Yeah, that is probably a little in the weeds at the moment. I am not ready to give guidance, let alone the seasonality. But AJ, I will make a more broad comment. Typically at Molina, we are a little front-end loaded in our earnings. We are typically anyplace between 55% and 70% front-end loaded across the year. That is not commentary on next year, but typically expect us to be a little front-end loaded.

AJ RiceAnalyst

Okay. All right. We have the base of $5.25 this year, $4 of embedded earnings, $9.25. I think you said $9.50. Somewhere in that range, there is sort of natural growth that comes with that number. Any other headwinds or tailwinds to consider? Again, I know you are not giving formal guidance, but to point to?

Mark KeimCFO

Yeah, let me walk through explicitly the math to when we say at least $9.50. We start with $5.25, which is guidance for 2026. We add the $4 of embedded earnings I talked about. In addition to that, Marketplace currently loses about $0.75 a share. We expect to at least get that to break even next year, so add another $0.75, you are at $10. When we say at least $9.50, one headwind you have to consider is for 2027, California UIS, or Undocumented Immigration Status members, will go back to fee-for-service due to federal regulation. That will be a $0.20-$0.25 headwind for us, so $10 comes on back to about $9.75. We say at least $9.50.

AJ RiceAnalyst

Okay. Okay. Is there natural growth almost every year you are going to get something that you would speak to at this point, or it is too early?

Mark KeimCFO

Well, the natural growth is in our revenue projections.

Mark KeimCFO

Okay. Remember, we're going 42 to 45.

Mark KeimCFO

The other thing, I'd just remind everybody that $9.50 in the building blocks is before improvement on the MLR.

Mark KeimCFO

Right in our legacy Medicaid business.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Access every statement, the English original, and speaker-by-speaker history with StockNow Pro.

View the full transcript with Pro

Other earnings calls that day

View calls from this day